Section I. Introduction and Overview 1. Introduction and overview of immunopathological mechanisms and future directions 2. Changing landscape in the field of paraneoplastic neurology: Personal Perspectives over a 35-year career 3. Pathogenesis and immunopathology of paraneoplastic disorders
Section II. Paraneoplastic neurological syndromes 4. Epidemiology of paraneoplastic neurologic syndromes 5. Clinical approach to diagnosis of paraneoplastic neurological syndromes 6. Overview of treatment strategies in paraneoplastic neurological syndromes 7. Methods to Detect Paraneoplastic Antibodies 8. Paraneoplastic encephalitis 9. Autoimmune and paraneoplastic seizures 10. Paraneoplastic Cerebellar and Brainstem Disorders 11. Paraneoplastic/autoimmune myelopathies 12. Paraneoplastic vision loss 13. Paraneoplastic movement disorders 14. Movement disorders associated with pediatric encephalitis 15. Paraneoplastic neuropathies and peripheral nerve hyperexcitability disorders 16. Paraneoplastic autonomic neuropathies and GI dysmotility 17. Myasthenia Gravis - Pathophysiology, diagnosis and treatment 18. Lambert-Eaton myasthenic syndrome 19. Paraneoplastic myopathies
Section III. Paraneoplastic autoantibodies 20. Intracellular paraneoplastic autoantibodies 21. Antibodies to neural cell surface and synaptic proteins in paraneoplastic neurologic syndromes 22. Optimizing the diagnostic performance of neural antibody testing for paraneoplastic and autoimmune encephalitis in clinical practice
Section IV. Paraneoplastic neurological and autoantibody accompaniments of cancer 23. Paraneoplastic Autoimmune Neurological Disorders associated with Thymoma 24. Paraneoplastic Neurologic Manifestations of Neuroendocrine tumors 25. Paraneoplastic Neurological Syndrome associated with Gynaecological and Breast malignancies 26. Hematological malignancies and hematopoietic stem cell transplantation 27. Paraneoplastic neurological syndrome and autoantibody accompaniments of germ cell tumors
Section V. Neurological complications of cancer immunotherapy 28. Neurological manifestations of autoimmunity with immune checkpoint inhibitors